News | March 17, 2024
Eris Lifesciences buys India formulation business of Biocon Biologics for Rs. 1,242 Cr
Both organisations enter into a long- term collaboration to expand patient access in India
Both organisations enter into a long- term collaboration to expand patient access in India
New facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million vials per day
Mungara has over 25+ years of experience in the supply chain domain
Sen spent a decade with Biocon and held various key roles,
Cureskin aims to disrupt the large and growing skin and hair care industry in India
This partnership marks a significant step for the Company towards establishing renewable energy power generation using hybrid open excess through solar and wind sources
India is contributing 13% to the global asthma burden and a disproportionate 43% of the global asthma deaths.
Vision loss due to Glaucoma can be prevented if it is detected and treated early
India has reached to nearly 6,000 bio-startups from 50 in the past 10 years
Group sales came in at 47.637 billion euros, down 1.2% on a currency- and portfolio-adjusted basis
Subscribe To Our Newsletter & Stay Updated
